We have a team dedicated to the detection,
evaluation and prevention of the risks associated with medicinal products
At Andrés Pintaluba, S.A., making sure we provide safe, effective and high-quality products is essential Our commitment to the medicinal products we market does not end the moment they are made available to the client, but is instead ongoing and permanent.
For this reason, we have a team specifically dedicated to pharmacovigilance: the detection, evaluation and prevention of possible adverse reactions (both for users as well as animals and the environment) associated with the medicinal products we sell.
Our main objectives are:
Early detection of adverse reactions and/or interactions that are thus far unknown.
Detection of increased frequency of (known) adverse reactions.
Dissemination of information necessary to improve the correct use of the medicinal products.
If a known or unknown adverse reaction is detected after administering any of our medicinal products, please contact us at the following e-mail address: pharmacovigilance@pintaluba.com or fill in the following form (the information you provide us with will be confidential).
To provide you with the best response, please fill in all fields. All data provided will be used solely for this purpose.
Please verify your e-mail address so that we can respond to your comments by e-mail. Your concerns/requests will be sent to the relevant department immediately.
